Core Viewpoint - HaiXi Pharmaceutical (02637) is set to list on the Hong Kong Stock Exchange on October 17, with pre-listing trading indicating a significant price increase from the initial offering price [1]. Group 1: Listing Details - HaiXi Pharmaceutical will officially list on October 17, 2023 [1]. - The initial offering price was set at HKD 86.4, while the dark trading price is currently at HKD 130.9, reflecting a 51.5% increase [1][2]. Group 2: Trading Performance - The dark trading volume reached 61,100 shares, with a highest price of HKD 176.0 and a lowest price of HKD 129.0 [2]. - The total market capitalization of HaiXi Pharmaceutical is approximately HKD 10.303 billion [2]. - The average trading price during the session was HKD 136.275, with a turnover rate of 0.08% [2].
海西新药暗盘盘初涨逾51% 每手赚2225港元